Clinical trial
Point of Care Testing Using FebriDx to Improve Antibiotic Use for Respiratory Tract Infections in Primary Care: a Mixed Methods Feasibility Study
NCT05534555 is registered in ClinicalTrials.gov with University of Southampton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Point of Care Testing Using FebriDx to Improve Antibiotic Use for Respiratory Tract Infections in Primary Care: a Mixed Methods Feasibility Study
- Lead sponsor
- University of Southampton
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2022
- Completion date
- October 31, 2024
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
lower resp tract infection